Evaluation of Clinical Practice Guidelines

Palileo-Villanueva, Lia M; Tumanan‐Mendoza, Bernadette A.; Silvestre, Maria Asuncion A.; Dans, Leonila F.; Dans, Antonio L.

doi:10.1002/9781119196150.ch7

Cited by 2 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An essential step prior to the evaluation of each guideline statement was the appraisal of the 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease. The evaluation of the quality and validity of this clinical guideline was performed by the TWG using the appraisal criteria described in Chapter 7, Appraisal of Clinical Practice Guidelines of Painless EBM 2nd ed, 2017 and was assessed to have complied with validity criteria 1 ) .…”

Section: Resultsmentioning

confidence: 99%

“…The first task of the TWG was to appraise the 2016 AHA/ACC Guidelines in its entirety. The overall appraisal of the CPG utilized the appraisal questions or checklist obtained from Painless EBM 2nd edition, 2017 (Chapter 7 Appraisal of Clinical Practice Guidelines) 1 ) . The TWG then discussed the methods on appraisal of the individual AHA/ACC statements and search strategies.…”

Section: Consensus Statement Development Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee

Abola

Golledge

Miyata

et al. 2020

JAT

View full text Add to dashboard Cite

Background: Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic modalities, and even patient treatment response. The Asian Pacific Society of Atherosclerosis and Vascular Diseases (APSAVD) thus coordinated the development of an Asia-Pacific Consensus Statement (APCS) on the Management of PAD. Objectives: The APSAVD aimed to accomplish the following: 1) determine the applicability of the 2016 AHA/ ACC guidelines on the Management of Patients with Lower Extremity Peripheral Artery Disease to the Asia-Pacific region; 2) review Asia-Pacific literature; and 3) increase the awareness of PAD. Methodology: A Steering Committee was organized to oversee development of the APCS, appoint a Technical Working Group (TWG) and Consensus Panel (CP). The TWG appraised the relevance of the 2016 AHA/ACC PAD Guideline and proposed recommendations which were reviewed by the CP using a modified Delphi technique. Results: A total of 91 recommendations were generated covering history and physical examination, diagnosis, and treatment of PAD-3 new recommendations, 31 adaptations and 57 adopted statements. This Asia-Pacific Consensus Statement on the Management of PAD constitutes the first for the Asia-Pacific Region. It is intended for use by health practitioners involved in preventing, diagnosing and treating patients with PAD and ultimately the patients and their families themselves.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Consensus Statement Development Methodsmentioning

confidence: 99%

Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee

Abola

Golledge

Miyata

et al. 2020

JAT

View full text Add to dashboard Cite

show abstract

“…Clinical practice guidelines (CPGs) are systematic aids for complex medical decision making and have the potential to drastically change health care practices . The intended outcome of CPGs is to improve the quality of health care by recommending effective interventions, reducing inappropriate variations in practice, and ensuring more efficient use of limited resources . In the perspective of policy makers, CPGs offer the means to bridge the gaps between policy, best practice, local contexts, and patient choice .…”

Section: Introductionmentioning

confidence: 99%

“…1 The intended outcome of CPGs is to improve the quality of health care by recommending effective interventions, reducing inappropriate variations in practice, and ensuring more efficient use of limited resources. 2 In the perspective of policy makers, CPGs offer the means to bridge the gaps between policy, best practice, local contexts, and patient choice. 3 With the recent implementation of Universal Health Care in the Philippines, CPGs are geared to inform cost-effective health policies, improve patient outcomes, and highlight gaps in research.…”

Section: Introductionmentioning

confidence: 99%

Appraisal of the methodological quality of clinical practice guidelines in the Philippines

Miguel

Silvestre

Imperial³

et al. 2019

Health Planning & Management

Self Cite

View full text Add to dashboard Cite

Summary Purpose The Republic of the Philippines has recently enacted the Universal Health Care Law, which mandates the Philippines Department of Health (DOH) to operationalize evidence‐based clinical practice guideline (CPG) development. As a baseline to the foregoing task, the aim of this study was to appraise the methodological quality of CPGs previously developed and currently being disseminated in the Philippines. A multimethod search for CPGs was implemented. CPGs were independently evaluated using a modified version of the Knowledge Management Plus CPG appraisal tool. Findings Eighty‐seven CPGs were included in the appraisal. Majority implemented processes to ensure validity, ie, consideration for patient groups, management options, benefits, and harms (99%), and indicated strength of their recommendations (89%). Seventy‐seven CPGs (89%) evaluated the evidence for local applicability. Of the 87 CPGs, 20 CPGs (23%) considered equity in the development process. The development process differed among CPGs with varying degrees of utilization of GRADE methodology (52%), disclosure of funding sources (72%), and engagement of technical support external to the development body (3%). Mean duration of CPG development was 1 year (SD 5.9 months), and mean interval between updates was 6 years and 1 month (SD 37.8 months). Conclusion Although most of the CPGs fulfilled essential criteria for quality recommendations (validity and applicability), equity considerations were limited. Furthermore, only half used the GRADE approach and development and dissemination practices differed substantially between CPGs. Thus, it is recommended that a standard CPG development process be made available by the DOH to be utilized by CPG developers in the Philippines.

show abstract

Evaluation of Clinical Practice Guidelines

Cited by 2 publications

References 13 publications

Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee

Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee

Appraisal of the methodological quality of clinical practice guidelines in the Philippines

Contact Info

Product

Resources

About